Johnson Richard G 4
4 · PHIBRO ANIMAL HEALTH CORP · Filed Sep 15, 2017
Insider Transaction Report
Form 4
Johnson Richard G
Chief Financial Officer
Transactions
- Exercise/Conversion
Option to purchase Common Stock
2017-09-13−15,900→ 6,479 totalExercise: $11.83From: 2013-03-01Exp: 2019-02-28→ Class A Common Stock (15,900 underlying) - Exercise/Conversion
Option to purchase Common Stock
2017-09-14−33,150→ 0 totalExercise: $11.83From: 2014-03-01Exp: 2019-02-28→ Class A Common Stock (33,150 underlying) - Exercise/Conversion
Option to purchase Common Stock
2017-09-14−6,479→ 0 totalExercise: $11.83From: 2013-03-01Exp: 2019-02-28→ Class A Common Stock (6,479 underlying) - Exercise/Conversion
Class A Common Stock
2017-09-13$11.83/sh+15,900$188,097→ 15,900 total - Sale
Class A Common Stock
2017-09-13$36.46/sh−15,900$579,714→ 0 total - Exercise/Conversion
Class A Common Stock
2017-09-14$11.83/sh+6,479$76,647→ 6,479 total - Sale
Class A Common Stock
2017-09-14$36.23/sh−6,479$234,734→ 0 total - Exercise/Conversion
Class A Common Stock
2017-09-14$11.83/sh+33,150$392,165→ 33,150 total - Sale
Class A Common Stock
2017-09-14$36.23/sh−33,150$1,201,025→ 0 total
Footnotes (4)
- [F1]The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.30 to $36.65, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.05 to $36.55, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.05 to $36.55, inclusive.